Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Brief look at how volume relates to index chart moves, demonstrating how volume spikes can confirm or warn against breakout signals.
28,655 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Ondas stock moved sharply higher after a strong Q1 revenue beat and higher full-year guidance. This piece breaks down...
When a CEO sells stock, investors listen. This article breaks down what the Electronic Arts CEO's roughly $1 million ...
Investors spotted a notable move in the mining space as Coeur Mining stock popped after an earnings beat. This piece ...
Jaguar (JAGX) 2025 earnings show a company shifting from product-driven revenue to licensing cash. This piece breaks ...
A fast-growing company with a software-led model and global expansion is catching investor attention. This growth sto...
After years of headwinds, Target is showing early signs of life. Yet the stock price tells a story of cautious optimi...
In the wake of a Supreme Court ruling voiding emergency tariffs, Trump warns trading partners they could face far har...
With a $475,000 mortgage and $175,000 in cash from a home sale, the big question is whether to pay down debt or inves...
A lone developer demonstrates embedding an image in a single Bitcoin transaction, igniting a debate over BIP-110 data...
When a large manager trims a position, questions follow. This article breaks down Hilton Capital’s $25 million GPIX s...
Oil prices surged as geopolitical tensions intensified, sending U.S. equities lower in early March trading. The S&P 5...